| Outcome | MTM-estimate (95% Crl) | Direct estimate (95% Crl) | Indirect estimate (95% Crl) | P-value for inconsistency |
---|---|---|---|---|---|
Diuretics vs. beta-blockers | Diabetes- incidence | 1.09 | 0.88 | 1.31 | 0.13 |
 |  | (0.80 to 1.44) | (0.59 to 1.32) | (0.88 to 2.17) |  |
Diuretics vs. ACE-inhibitors | Diabetes- incidence | 1.43 | 1.54 | 1.25 | 0.24 |
 |  | (1.12 to 1.83) | (1.14 to 2.10) | (0.89 to 1.79) |  |
Diuretics vs. placebo | All-cause mortality | 0.88 | 0.89 | 0.80 | 0.29 |
 |  | (0.80 to 0.95) | (0.82 to 0.97) | (0.68 to 0.96) |  |
Beta-blockers vs. ARB | Stroke | 1.23 | 1.34 | 1.00 | 0.17 |
 |  | (0.96 to 1.49) | (1.03 to 1.74) | (0.69 to 1.41) |  |
Beta-blockers vs. ARB | Diabetes- incidence | 1.46 | 1.32 | 1.98 | 0.13 |
 |  | (1.15 to 1.98) | (0.97 to 1.82) | (1.26 to 3.40) |  |
ACE- inhibitors vs. CCB | All-cause mortality | 1.02 | 1.05 | 0.95 | 0.21 |
 |  | (0.95 to 1.10) | (0.96 to 1.13) | (0.82 to 1.09) |  |
ACE- inhibitors vs. CCB | Heart fail ure | 0.82 | 0.79 | 0.68 | 0.29 |
 |  | (0.69 to 0.94) | (0.67 to 0.95) | (0.52 to 0.90) |  |
ACE-inhibitors vs. placebo | All-cause mortality | 0.87 | 1.30 | 0.86 | 0.08 |
 |  | (0.79 to 0.96) | (0.82 to 2.14) | (0.77 to 0.95) |  |
Diuretics and/or beta-blockers vs. placebo | All-cause mortality | 0.82 | 0.57 | 0.85 | 0.06 |
 |  | (0.73 to 0.92) | (0.34 to 0.84) | (0.75 to 0.96) |  |
CCB vs. ARB | Stroke | 0.91 | 0.86 | 1.15 | 0.19 |
 |  | (0.75 to 1.11) | (0.69 to 1.05) | (0.78 to 1.70) |  |
CCB vs. ARB | Diabetes- incidence | 1.25 | 1.29 | 0.86 | 0.14 |
 |  | (1.02 to 1.56) | (1.07 to 1.71) | (0.49 to 1.49) |  |